0 Комментарии
0 Поделились
522 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Статьи пользователей
-
Marketplace
-
Форумы
-
Войдите, чтобы отмечать, делиться и комментировать!
-
In Vivo CRO Market to Reach USD 10.07 Billion by 2033, Driven by Growing Global Research StandardsThe global in vivo CRO market size was valued at USD 4.95 billion in 2024, and it is projected to reach USD 5.36 billion in 2025 to USD 10.07 billion by 2033, growing at a CAGR of 8.2% during the forecast period (2025–2033). The rising international standards adoption by contract researchers in emerging nations is projected to improve demand for...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Clinical Trials SMO Market to Reach USD 3.2 Billion by 2034 | CAGR 6.3%According to a newly published market research report by 24LifeSciences, global Clinical Trials Site Management Organizations (SMO) market was valued at USD 1.84 billion in 2025 and is projected to reach USD 3.2 billion by 2034, growing at a compound annual growth rate (CAGR) of 6.3% during the forecast period 2026–2034. Clinical Trials Site Management Organizations are specialized...0 Комментарии 0 Поделились 558 Просмотры 0 предпросмотр
-
In Vivo Toxicology Market to Reach USD 6.37 Billion by 2031 | CAGR 6.1%According to a newly published market research report by 24LifeSciences, the global In Vivo Toxicology market was valued at USD 4.27 billion in 2024 and is projected to reach USD 6.37 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.1% during the forecast period 20252031. In Vivo Toxicology represents an essential component of preclinical drug development, employing whole...0 Комментарии 0 Поделились 83 Просмотры 0 предпросмотр
-
In Vivo Toxicology Market to Reach USD 6.37 Billion by 2031 | CAGR 6.1%According to a newly published market research report by 24LifeSciences, the global In Vivo Toxicology market was valued at USD 4.27 billion in 2024 and is projected to reach USD 6.37 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.1% during the forecast period 20252031. In Vivo Toxicology represents an essential component of preclinical drug development, employing whole...0 Комментарии 0 Поделились 77 Просмотры 0 предпросмотр
Спонсоры
Спонсоры